🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
0.7545
-0.0552 (-6.82%)
Nov 20, 2026, 1:59 PM EST - Market open

Sonoma Pharmaceuticals Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
23.4919.5314.2912.7413.2712.63
Revenue Growth
38.69%36.68%12.20%-4.05%5.10%-32.21%
Cost of Revenue
14.2812.118.827.998.88.64
Gross Profit
9.227.425.474.754.483.99
Selling, General & Admin
7.837.617.367.588.849.76
Research & Development
2.172.271.811.870.210.13
Operating Expenses
9.999.889.189.459.059.88
Operating Income
-0.78-2.46-3.71-4.7-4.57-5.89
Interest Expense
------0.01
Currency Exchange Gain (Loss)
1.451.450.24-0.83-0.69-0.58
Other Non Operating Income (Expenses)
-2.06-2.40.560.50.080.19
EBT Excluding Unusual Items
-1.39-3.42-2.91-5.03-5.18-6.29
Gain (Loss) on Sale of Assets
-----0.15
Other Unusual Items
-----0.72
Pretax Income
-1.39-3.42-2.91-5.03-5.18-5.42
Income Tax Expense
0.4-0.240.55-0.2-0.03-0.33
Earnings From Continuing Operations
-1.8-3.18-3.46-4.84-5.15-5.09
Net Income
-1.8-3.18-3.46-4.84-5.15-5.09
Net Income to Common
-1.8-3.18-3.46-4.84-5.15-5.09
Net Income Growth
------
Shares Outstanding (Basic)
321000
Shares Outstanding (Diluted)
321000
Shares Change
91.89%35.70%172.75%168.12%27.93%32.92%
EPS (Basic)
-0.59-1.89-2.79-10.63-30.35-38.34
EPS (Diluted)
-0.59-1.89-2.79-10.63-30.35-38.34
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-2.79-4.13-0.17-2.4-6.42-4.39
Free Cash Flow Per Share
-0.91-2.45-0.14-5.28-37.84-33.06
Gross Margin
39.23%37.97%38.25%37.26%33.73%31.62%
Operating Margin
-3.32%-12.60%-25.97%-36.91%-34.43%-46.62%
Profit Margin
-7.65%-16.26%-24.20%-37.97%-38.81%-40.28%
Free Cash Flow Margin
-11.87%-21.12%-1.18%-18.85%-48.38%-34.72%
EBITDA
-0.65-2.32-3.57-4.53-4.45-5.7
EBITDA Margin
-2.77%-11.89%-25.00%-35.53%-33.49%-45.15%
D&A For EBITDA
0.130.140.140.180.130.19
EBIT
-0.78-2.46-3.71-4.7-4.57-5.89
EBIT Margin
-3.32%-12.60%-25.97%-36.91%-34.43%-46.62%
Advertising Expenses
-0.090.190.160.160.09
SEC Filings: 10-K · 10-Q